rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Teri Loxam

Director

Company insider

Files Form 4 as: Director, Vaxcyte; Chief Financial Officer, COMPASS Pathways; Chief Financial Officer, SQZ Biotechnologies Co.

Every Form 4 they filed

In numbers

Trades disclosed
44
Buys
0
Sells
2
Bought
$0
Sold
$1.3M
Companies
3
Companies where not an officer
1
First trade
29 Oct 2020
Last trade
15 Jun 2026
Last filed
16 Jun 2026

Companies traded

Where they are an officer
CMPS COMPASS PathwaysOfficer · Biotechnology · last 26 Mar 20260 buys · 0 sells
SQZ Biotechnologies CoOfficer · last 23 Feb 20210 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PCVX VaxcyteDirector · Biotechnology · last 15 Jun 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 16 Jun 2026PCVX VaxcyteBiotechnologySEC FORM 4 Code A—2,265 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—11,389 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—11,389 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX VaxcyteBiotechnologySEC FORM 4 Code A—2,265 at $0.00filing
26 Mar 2026filed 27 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
26 Mar 2026filed 27 Mar 2026CMPS COMPASS Pathwaysoption or derivative · BiotechnologySEC FORM 4 Code A—157,635 at $0.00filing
26 Mar 2026filed 27 Mar 2026CMPS COMPASS Pathwaysoption or derivative · BiotechnologySEC FORM 4 Code A—157,635 at $0.00filing
26 Mar 2026filed 27 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
11 Mar 2026filed 13 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code F$12K1,781 at $6.89filing
11 Mar 2026filed 13 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code F$12K1,781 at $6.89filing
2 Mar 2026filed 3 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code F$31K4,467 at $7.02filing
2 Mar 2026filed 3 Mar 2026CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code F$31K4,467 at $7.02filing
12 Jun 2025filed 16 Jun 2025PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—15,372 at $0.00filing
12 Jun 2025filed 16 Jun 2025PCVX VaxcyteBiotechnologySEC FORM 4 Code A—3,041 at $0.00filing
11 Mar 2025filed 13 Mar 2025CMPS COMPASS Pathwaysoption or derivative · BiotechnologySEC FORM 4 Code A—76,000 at $0.00filing
11 Mar 2025filed 13 Mar 2025CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
3 Mar 2025filed 4 Mar 2025CMPS COMPASS PathwaysBiotechnologySEC FORM 4 Code F$16K4,468 at $3.67filing
15 Jan 2025filed 17 Jan 2025PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code M—6,250 at $0.00filing
15 Jan 2025filed 17 Jan 2025PCVX VaxcyteBiotechnologySEC FORM 4 Code M$142K6,250 at $22.70filing
15 Jan 2025filed 17 Jan 2025PCVX VaxcyteBiotechnologySEC FORM 4 Sold$12K146 at $80.46filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Kabir NathChief Executive Officer · Chief Executive Officer at COMPASS Pathways, filing Form 4 there in the last year
Gino SantiniDirector · Director at COMPASS Pathways, filing Form 4 there in the last year
Wayne Joseph RileyDirector · Director at COMPASS Pathways, filing Form 4 there in the last year
David Y. NortonDirector · Director at COMPASS Pathways, filing Form 4 there in the last year
Justin D. GoverDirector · Director at COMPASS Pathways, filing Form 4 there in the last year
Elvia CowanSVP, Finance & CAO · Also traded PCVX in the last 90 days
Jim WassilEVP, Chief Scientific Ofc, COO · Also traded PCVX in the last 90 days
Harpreet S. DhaliwalChief Technical Ops Officer · Also traded PCVX in the last 90 days